Basic information |
Metabolite name | 3-Hydroxyanthranilic acid |
HMDB0001476 | |
C00632 | |
86 | |
Synonyms | 3-Hydroxyanthranilic acid; |
No. of studies | 14 |
Relationship between 3-Hydroxyanthranilic acid and depression (count: 14) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M046 | Type1 | LPS group vs. control group | Dorsal hippocampus | C57BL/6N mouse | Up |
Study M1019 | Type1 | depression group vs. control group | Serum | Human | Down |
Study M1023 | Type1 | CRS group vs. control group | Faece | C57BL/6 J mouse | Down |
Study M1107 | Type1 | CRS group vs. control group | Serum | C57/6 J mouse | Up |
Study M1107 | Type2 | CRS + FMT of healthy controls group vs. CRS group | Serum | C57/6 J mouse | Down |
Study M1108 | Type1 | CRS group vs. control group | Prefrontal cortex | C57/6 J mouse | Up |
Study M1108 | Type1 | CRS group vs. control group | Serum | C57/6 J mouse | Up |
Study M1108 | Type2 | CRS + Roseburia Intestinalis. group vs. CRS group | Prefrontal cortex | C57/6 J mouse | Down |
Study M1108 | Type2 | CRS + Roseburia Intestinalis. group vs. CRS group | Serum | C57/6 J mouse | Down |
Study M126 | Type1 | LPS group vs. control group | Brain | CD-1 mouse | Up |
Study M522 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
Study M522 | Type2 | CUMS + NaP group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Up |
Study M683 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Down |
Study M683 | Type2 | CUMS + high dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
Study M683 | Type2 | CUMS + middle dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
Study M683 | Type2 | CUMS + low dose of Radix Bupleuri and Radix Paeoniae Alba drug pair group vs. CUMS group | Urine | Sprague-Dawley rat | Up |
Study M728 | Type1 | CRS group vs. control group | Serum | C57BL/6 J mouse | Up |
Study M732 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
Study M732 | Type1 | CUMS + high dose of propionate group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
Study M732 | Type2 | CUMS + low dose of propionate group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
Study M732 | Type2 | CUMS + middle dose of propionate group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
Study M767 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Up |
Study M767 | Type2 | CUMS + HLJDD group vs. CUMS group | Hippocampus | C57BL/6 mouse | Down |
Study M787 | Type1 | CRS group vs. control group | Colon | Wistar rat | Up |
Study M874 | Type1 | ovariectomy group vs. control group | Urine | Sprague-Dawley rat | Down |
Study M874 | Type2 | ovariectomy + Panax ginseng group vs. ovariectomy group | Urine | Sprague-Dawley rat | Up |
Study M879 | Type1 | unipolar depression group vs. control group | Plasma | Human | Down |